Skip to main navigation Skip to search Skip to main content

Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
JournalMultiple Sclerosis Journal
StatePublished - 2025.08.1

Cite this